Hims & Hers officer plans sale of 6,236 shares
Hims & Hers Health, Inc. (HIMS) is the issuer for which Soleil Boughton, identified as an officer, has filed a Rule 144 notice covering potential sales of Class A common stock through Fidelity Brokerage Services LLC.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. (HIMS) is the issuer for which Soleil Boughton, identified as an officer, has filed a Rule 144 notice covering potential sales of Class A common stock through Fidelity Brokerage Services LLC. The notice lists 6,236 shares of Class A stock with an aggregate market value of $173,734.96 and notes that 224,935,790 shares of Class A were outstanding as of September 16, 2026.
The filing also describes restricted stock vesting awards of 2,775 shares on September 15, 2025 and 3,461 shares on August 15, 2026 as compensation, and reports prior sales during the past three months totaling 28,569 shares of Class A stock for aggregate proceeds of $789,773.19.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for HIMS (Hims & Hers Health, Inc.)?
What recent HIMS stock sales by Soleil Boughton are disclosed?
What restricted stock vesting is reported for HIMS in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.